Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Article

Prenatal developmental toxicity evaluation of IDM01, a botanical composition of 4‑hydroxyisoleucine and trigonelline based standardized fenugreek seed extract, during organogenesis period of pregnancy in rats

Pallavi Deshpande, Vishwaraman Mohan, K R Raghunatha Reddy, V R L N Manjunath, Prasad Thakurdesai.

The present study was undertaken to assess the developmental toxicity of botanical composition of standardized fenugreek seed extract with makers 4‑hydroxyisoleucine and trigonelline (IDM01) during organogenesis period of pregnancy in rats in accordance with OECD guideline (No. 414). Pregnant rats were administered by gavage at 125, 250, and 500 mg/kg per day of IDM01 over the exposure period of gestational days 5–19 (GD5-GD19). The vehicle control (VC) group was also maintained. The cesarean sections of dams on GD20 were done. All fetuses were examined for external, visceral, and skeletal alterations. IDM01 treatment did not adversely affect maternal parameters (body weights, uterine weight, uterine observations, feed consumption, and gross pathology), or fetal developmental parameters (fetal body weight, crown-rump length, sex ratio and incidence of anomalies) as compared to VC group. In conclusion, the prenatal oral exposure of IDM01 during organogenesis period to pregnant female rats is without any of maternal or developmental (fetotoxicity or teratogenicity) with "No Observed Adverse Effect Level” (NOAEL) greater than 500 mg/kg/day.

Key words: Developmental toxicity; Fenugreek seeds extract; 4-hydroxyisoleucine; trigonelline; OECD Test No. 414

Share this Article

American Journal of Physiology, Biochemistry and Pharmacology


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.